Is the medical use disclosure standard different for novelty and sufficiency?, Managing IP, 2024

Eva Ehlich and Anja Fux of Maiwald discuss an EPO board ruling relating to the standard of disclosure concerning the novelty and sufficiency of a therapeutic effect in the context of existing case law.

To the article

作者

Dr. Eva Ehlich

Partner

German Patent Attorney

European Patent Attorney

UPC Representative

Chemist

Dr. Anja Fux

Associate

German Patent Attorney

European Patent Attorney

UPC Representative

M.Sc. Biochemistry